Iovance Biotherapeutics Inc
(IOVA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Operating Expenses | 705 | 1,722 | 1,628 | 1,646 | 3,136 |
| Operating Income | -705 | -1,722 | -1,628 | -1,646 | -3,136 |
| Interest Expense | 342 | 1,596 | 127 | 111 | 89 |
| Other Income | 0 | 6,785 | 1,081 | 1,430 | -2,548 |
| Pre-tax Income | -1,047 | 3,466 | -674 | -327 | -5,773 |
| Net Income Continuous | -1,047 | 3,466 | -674 | -327 | -5,773 |
| Net Income | $-1,047 | $3,466 | $-674 | $-327 | $-5,773 |
| EPS Basic Total Ops | -1.28 | 4.11 | -0.86 | 0.00 | -7.39 |
| EPS Basic Continuous Ops | -1.28 | 4.53 | -0.86 | -0.42 | -7.39 |
| EPS Diluted Total Ops | -1.28 | 4.11 | -0.86 | 0.00 | -7.39 |
| EPS Diluted Continuous Ops | -1.28 | 4.53 | -0.86 | -0.42 | -7.39 |
| EBITDA(a) | $-703 | $-1,721 | $-1,128 | $-1,645 | $-3,135 |